Jeuveau™ for Frown Lines (cheaper than Botox®!)

jeauveau neurotoxinIf you’ve been seeking a cost effective alternative treatment for frown lines, then you have reason to celebrate! Meet your new favorite neurotoxin – Jeuveau.

The FDA has approved a new neurotoxin treatment called Jeuveau™ for improving severe glabellar lines (aka “frown lines” and “11’s”) and it’s a hard line competitor against products like Botox, Dysport, and Xeomin.

What is Jeuveau™?

Jeuveau (parabotulinumtoxinA-xvfs) is an FDA approved neurotoxin (a proprietary 900 kDa purified botulinum toxin type A formulation) slated for release in the Spring of 2019.

It is manufactured by Daewoong and Evolus holds the exclusive right to sell in the U.S.  Evolus is a relatively new company to the aesthetic market, Jeuveau being their first product launched.

Even though Jeuveau is approved specifically for reducing the signs of aging between the eyebrows, there’s no doubt that it will be used off-label in other areas of the face (just as Botox, Xeomin and Dysport are!).

How does Jeuveau Compare?

First off, Jeuveau is projected to be between 20% and 25% cheaper than Botox. Even though it is manufactured much like Botox, the proprietary Hi-Pure Tecnology  makes it freeze-dried.

This makes is way less expensive to ship since it doesn’t have to be shipped with refrigeration, making the cost lower than other neurotoxins.

As all neurotoxins, Jeuveau prevents communication between a nerve and the muscle it controls. Blocking this communication forces the muscles to relax, smoothing the appearance of lines and wrinkles.

And, it typically takes 20-50 units, like any other neurotoxin product, to smooth severe glabellar lines.

The full effects of Jeuveau may take up to 10 days to be realized. This is about the same as Dysport. Botox and Xeomin treatments can take from as little as 5 days to as long as 2 weeks to completely settle in.

You should enjoy the results from Jeuveau for anywhere from 3-6 months. Depending on your own muscle structure and the areas you have treated, this can be up to two months longer than results from Jeuveau’s biggest competitors.

The greater your muscle mass in the treated area, the more quickly your nerve communication will recover.

FDA approval of this Botox alternative is a game changer for the injectable skincare market.

(and Allergan must think Jeuveau is serious competition as they have asked the International Trade Commission (ITC) to investigate Evolus for allegedly stealing trade secrets.)

Regardless, reducing frown lines in your face is about to get much cheaper guys! Get ready to kick off your spring season with a fresh face and fatter pocketbook with this strong contender in the fight against aging skin.beautyblackbook keeping you in the know